<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1420">
  <stage>Registered</stage>
  <submitdate>26/06/2006</submitdate>
  <approvaldate>22/01/2007</approvaldate>
  <actrnumber>ACTRN12607000066482</actrnumber>
  <trial_identification>
    <studytitle>Steroids and colonic surgery</studytitle>
    <scientifictitle>The influence of pre-operative dexamethasone on post operative recovery and fatigue in patients undergoing elective colonic resection</scientifictitle>
    <utrn />
    <trialacronym>nil</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Patients undergoing elective colonic resection/surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>8 mg of intravenous dexamethasone 90 minutes prior to incision</interventions>
    <comparator>Placebo (saline 90 minutes prior to incision)</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Fatigue </outcome>
      <timepoint>Pre-op and days 1, 2, 3, 7, 30, 60, 90 </timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Local and plasma cytokine concentration</outcome>
      <timepoint>Morning of day 1</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Nausea and vomiting</outcome>
      <timepoint>Pre-op and days 1, 2 and 3</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Pain</outcome>
      <timepoint>Pre-op and days 1,2 and 3</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Return to normal activity</outcome>
      <timepoint>Assessed at days 3, 7, 30,  60 and 90</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Sleep</outcome>
      <timepoint>Pre-op and days 1,2 and 3</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Appetite</outcome>
      <timepoint>Pre-op and days 1,2 and 3</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Anxiety</outcome>
      <timepoint>Pre-op and days 1,2 and 3</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age 18 yrs and overGender : male and female</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Sensitivity to Dexamethasone or any contraindication to use of dexamethasone, long term steroid useInclusion: colonic surgery</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes containing coded numbers</concealment>
    <sequence>Computer generated random numbers</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>subjects and assesors (the medical team and the investigators) will be blinded as to which treatment the patient is recieving pre-operatively</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>27/06/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>70</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Associate Professor Andrew Hill</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Auckland Medical Research Foundation</fundingname>
      <fundingaddress>Auckland University
Auckland</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Health Research Council of New Zealand</fundingname>
      <fundingaddress>PO Box 5541, Wellesley Street, Auckland, 1141, New Zealand</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Kamran Zargar</sponsorname>
      <sponsoraddress>Department of Surgery University of Auckland Middlemore Hospital PO Box 93311 Otahuhu Auckland</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Fatigue is a common and significant problem after major colonic surgery. It is thought that one cause of this fatigue is the production of inflammatory mediators, including cytokines, in the peritoneal cavity. It is known that the production of cytokines can be decreased by the use of steroids. Thus, in order to decrease fatigue after surgery, consecutive patients undergoing major colonic surgery will be randomised to 2 groups. One will receive 8 mg of preoperative Dexamethasone (intervention group) and the other will receive saline (Placebo group). We will measure fatigue, pain, nausea and vomiting scores and measures of functional recovery after surgery in order to assess that impact of the preoperative steroid.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Middlemore hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>NTY/06//03/020</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Kamran Zargar Shoshtari</name>
      <address>Department of Surgery 
University of Auckland
Middlemore Hospital
PO Box 93311 Otahuhu Auckland</address>
      <phone>+64 9 2760000 ext 2100</phone>
      <fax>+64 9 2679482</fax>
      <email>kamran.zargar@gmail.com</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Assoc. Prof Andrew G. Hill</name>
      <address>Department of Surgery 
University of Auckland
Middlemore Hospital
PO Box 93311 Otahuhu Auckland</address>
      <phone>+64 9 276 0000 ext 8424</phone>
      <fax>+64 9 2679482</fax>
      <email>ahill@middlemore.co.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>